Associate Professor Melissa Eastgate is the Executive Director of Cancer Care Services at the RBWH, and the stream lead Metro North HHS Cancer Care Services. Melissa is the immediate past Chair of the Medical Oncology Group of Australia. Melissa completed her medical degree at the University of Queensland and gained her FRACP in Medical Onoclogy in 2004. Since then she has worked at the RBWH as a medical oncologist, with her main clinical interests being melanoma and gastrointestinal cancers, in which areas she is an active researcher. Melissa established the Melanoma MDT at the RBWH. Melissa supervises physician trainees throughout their training and is the previous Chair of the RACP Advanced Training Committee for Medical Oncology. Melissa has a strong interest in enabling access to care for patients, having provided outreach services to Bundaberg for nine years, and leading the establishment of the Telechemotherapy service in Longreach and Barcaldine.
Safety of bevacizumab used in routine practice in patients with metastatic colorectal cancer
Dzienis, M., Malczewski, A., Goh, J., Hughes, B., Eastgate, M., Wyld, D. and Burge, M. (2012). Safety of bevacizumab used in routine practice in patients with metastatic colorectal cancer. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Program and Abstracts: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting, Brisbane, QLD Australia, 8-10 August 2012. Wiley-Blackwell Publishing.
